Sirolimus: a comprehensive review (Q34515537)

2 August 2017

1 reference

title

Sirolimus: a comprehensive review (English)

1 reference

2 August 2017

1 reference

Kahan BD

1

1 reference

PubMed ID

11825325

2 August 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

Expert Opinion on Pharmacotherapy

2 August 2017

1 reference

2 August 2017

2

1 reference

2 August 2017

11

1 reference

2 August 2017

1903-1917

1 reference

Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients

2 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Rapamycin: a novel immunosuppressive macrolide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Immunopharmacology of rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Rapamycin resistance tied to defective regulation of p27Kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Immunopurified mammalian target of rapamycin phosphorylates and activates p70 S6 kinase alpha in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Regulation of eIF-4E BP1 phosphorylation by mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

A calcineurin antagonist-free induction strategy for immunosuppression in cadaveric kidney transplant recipients at risk for delayed graft function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Sirolimus improves the two-year outcome of renal allografts in African-American patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Sirolimus permits steroid withdrawal from a cyclosporine regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: risk factors, incidence, progression, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Raf/MAPK and rapamycin-sensitive pathways mediate the anti-apoptotic function of p21Ras in IL-3-dependent hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.11.1903

Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.28.727

Identifiers

DOI

10.1517/14656566.2.11.1903

1 reference

2 August 2017

1 reference

PubMed ID

11825325